SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-24-013443
Filing Date
2024-02-13
Accepted
2024-02-13 17:21:57
Documents
2
Group Members
HOPEWELL RESOURCES HOLDINGS LTD HOPELAV AQUA LTD AQUAORIENTAL SPRING VENTURE LTD ORIENYI SHI

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO SCHEDULE 13G ea193270-13ga3lavbio5_terns.htm SC 13G/A 161367
2 AGREEMENT OF JOINT FILING ea193270ex99-1_terns.htm EX-99.1 11815
  Complete submission text file 0001213900-24-013443.txt   175031
Mailing Address C/O ESTERA TRUST (CAYMAN) LIMITED 75 FORT STREET, PO BOX 1350 GRAND CAYMAN E9 KY1-1108
Business Address C/O ESTERA TRUST (CAYMAN) LIMITED 75 FORT STREET, PO BOX 1350 GRAND CAYMAN E9 KY1-1108 345-640-0540
LAV Biosciences Fund V, L.P. (Filed by) CIK: 0001764435 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Subject) CIK: 0001831363 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92116 | Film No.: 24630100
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)